- DocumentBlog - Asahi 3uploaded byAerst2
- DocumentBlog - Asahi 2uploaded byAerst2
- DocumentBlog - Asahi 2.5uploaded byAerst2
- DocumentBlog - 09-515auploaded byAerst2
- Document10-311uploaded byAerst2
- Document09-184uploaded byAerst2
- DocumentSilicon (11-163)uploaded byAerst2
- DocumentCNH Am (08-945-GMS)uploaded byAerst2
- DocumentShelbyzyme (09-768)uploaded byAerst2
- DocumentVelcera (11-134-GMS)uploaded byAerst2
- DocumentHuman Genome (11-082)uploaded byAerst2
- Document10-595uploaded byAerst2
- Document10-595 (Special Master Op)uploaded byAerst2
- Document07-826uploaded byAerst2
- Document09-152uploaded byAerst2
- Document09-2118 - judgmentuploaded byAerst2
- Document09-2118uploaded byAerst2
- Document07-823 - Medtronic - 3-30-2011uploaded byAerst2
- DocumentFifth Market (08 530 GMS)uploaded byAerst2
- Document08-266uploaded byAerst2
- Document09-943uploaded byAerst2
- Document07-127uploaded byAerst2
- DocumentEdwards (08-91)uploaded byAerst2
- DocumentPower (04-1371)uploaded byAerst2
- Document10-47uploaded byAerst2
- Document09-264-SLRuploaded byAerst2
- DocumentBrigham, 08-464uploaded byAerst2
- Document09-605uploaded byAerst2
- Document10-128uploaded byAerst2
- DocumentAllergan (09-511)uploaded byAerst2
- Document10-094uploaded byAerst2
- Document10-503uploaded byAerst2
- Document09-234uploaded byAerst2
- Document08-542x2uploaded byAerst2
- Document08-542xuploaded byAerst2
- Document09-80uploaded byAerst2
- Document10-308uploaded byAerst2
- Document10-308uploaded byAerst2
- Document08-823xuploaded byAerst2
- Document07-272Buploaded byAerst2
- Document08-63uploaded byAerst2
- Document09-333uploaded byAerst2
- DocumentGirafa (07-787-SLR)uploaded byAerst2
- Document09-333uploaded byAerst2
- DocumentCordance (06-491) (Equitable Relief)uploaded byAerst2
- Document06-644uploaded byAerst2
- Document09-871uploaded byAerst2
- Document07-680uploaded byAerst2
- Document07-680uploaded byAerst2